Ark Biotech
Latest round
- Seed
Last raised
- Dec 2021
Total raised
- $2.5M
Investors
- 2
About Ark Biotech
Ark Biotech Inc. develops advanced simulation software for bioprocess management, enhancing efficiency in biopharmaceutical development.Founded in 2021 in New York, US, Ark Biotech Inc. specializes in high-fidelity simulation software for bioprocess management.000 mn.Ark provides high-fidelity simulation software designed to optimize bioprocess management across various stages of development, from early-stage process development to commercial manufacturing. The software enables users to simulate thousands of experiments in parallel, improving decision-making and accelerating time to market. It allows scientists to test hypotheses in silico, minimizing the need for physical experiments, thus enhancing process robustness and efficiency. Ark's offerings are tailored for professionals in biopharmaceutical development, specifically targeting cell culture processes to predict and analyze performance metrics such as titer, viability, and metabolic indicators.Ark's revenue model is structured around software subscriptions and partnerships, facilitating B2B transactions with clients in the biopharmaceutical sector. Clients pay for access to Ark's advanced simulation tools, which provide services such as model calibration, process optimization, and ongoing updates to ensure compliance with the latest security standards. The company’s flagship offerings, which include a comprehensive library of bioreactor models and customizable simulation options, are accessed through tiered subscription plans that cater to varying user needs and organizational scales.Ark Biotech Inc. The company is focused on developing new simulation tools aimed at improving bioprocess strategies. Furthermore, Ark aims to penetrate additional markets in Europe and Asia by the end of 2023, thereby broadening its global footprint and customer base.
Who invested in Ark Biotech
2 investors across 1 round
See all investors in Ark Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 10, 2021
Amount
$2.5M
Investors
Questions about Ark Biotech
Who invested in Ark Biotech?
Ark Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ark Biotech raised?
Ark Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ark Biotech last raise money?
Ark Biotech's most recent round on record is a Seed, in Dec 2021.
What does Ark Biotech do?
Ark Biotech is a biotechnology company.
Where is Ark Biotech headquartered?
Ark Biotech is headquartered in New York, US.
Which VCs invest in companies like Ark Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ark Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ark Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.